CD8A and neoplasm: The net result, therefore, was a five-fold increase in the intra-tumor CD8:Treg ratio (13.4 for DTA-1-treated compared with 2.6 for IgG-treated mice, p = 0.05), favoring the effector population (Figure 3B).